India, Dec. 18 -- image credit- freepik

Global pharma major Lupin Limited has announced that its subsidiaries in the Philippines (Multicare Pharmaceuticals) and Brazil (MedQuimica) have signed an exclusive licensing agreement with Neopharmed Gentili S.p.A, an Italian pharmaceutical company, for marketing and promotional rights for the Gastroenterology brand, Plasil(R)(metoclopramide),in their respective markets.

This agreement will enhance Lupin's gastroenterology portfolio and expand its presence in emerging markets. Neopharmed will oversee product supply in the Philippines, ensuring quality and compliance with global standards. In Brazil, production will be shifted to Medquimica's manufacturing facility.

"Our partnership with Neophar...